Glenmark, Mankind Pharma ink licensing pact to co-market diabetes drug Remogliflozin Medical Dialogues Bureau24 Dec 2019 12:05 PM ISTUnder the sub-licensing agreement, Mankind will market diabetes drug Remogliflozin Etabonate under its own trademark while Glenmark will manufacture...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 9:45 AM ISTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Allergan acute migraine drug Ubrelvy wins USFDA approval Medical Dialogues Bureau24 Dec 2019 9:30 AM ISTAllergan Plc's drug, Ubrelvy, is the first oral version of a new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors to win the...
Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations Medical Dialogues Bureau24 Dec 2019 9:00 AM ISTThe vaccine, Ervebo, was approved by the U.S. Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that...
After Cipla, Glenmark Digihaler secures NPPA nod for separate price; Details Farhat Nasim23 Dec 2019 4:28 PM ISTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA) recently approved the price for the digital dose counter brand ’Digihaler’...
Johnson and Johnson wins baby powder-cancer litigation case in US Medical Dialogues Bureau23 Dec 2019 12:43 PM ISTThe litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson (JnJ), finding Johnson's baby powder...
Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA Medical Dialogues Bureau23 Dec 2019 10:00 AM IST"Glenmark will continue to fully cooperate with the FDA as the agency evaluates ranitidine products for the presence of NDMA (a substance that could...
Lupin to provide access to latest developments in field of gastroenterology in India Medical Dialogues Bureau23 Dec 2019 9:45 AM ISTThrough this initiative, Lupin aims to bring in global educational material and provide access to the latest developments in the field of...
GSK fails to secure USFDA nod for HIV injection Cabenuva Medical Dialogues Bureau23 Dec 2019 9:40 AM ISTThe unit of GSK, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new...
IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney Medical Dialogues Bureau23 Dec 2019 9:00 AM ISTIt has focused on breast tumours, but now the U.S. Food and Drug Administration (USFDA) approved new uses, such as against tumours in the kidney,...
NPPA fixes price of Cipla Synchrobreathe inhaler device; Details Medical Dialogues Bureau22 Dec 2019 2:26 PM ISTNew Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil Medical Dialogues Bureau22 Dec 2019 10:01 AM IST"Today, the manufacturing cost of atovaquone is believed to pose a barrier to the widespread use of atovaquone-proguanil based products in...
